Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review (Q28475841)

5

0 references

Agnes I. Vitry

object named as

Agnes I Vitry

7

0 references

Joel Lexchin

4

object named as

Joel Lexchin

0 references

author name string

Peter R Mansfield

2

0 references

Brett D Montgomery

3

0 references

Noordin Othman

Creative Commons Attribution 4.0 International

6

0 references

language of work or name

English

0 references

publication date

19 October 2010

3 references

25 June 2019

27 October 2022

7 February 2024

3 references

25 June 2019

27 October 2022

7 February 2024

7

0 references

page(s)

e1000352

0 references

issue

10

0 references

copyright license

3 references

Europe PubMed Central

25 June 2019

Europe PubMed Central

27 October 2022

Quality of pharmaceutical advertisements in medical journals: a systematic review

Europe PubMed Central

7 February 2024

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Characteristics and impact of drug detailing for gabapentin

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Educating health professionals about drug and device promotion: advocates' recommendations

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Interactions between pharmaceutical representatives and doctors in training. A thematic review

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

19 March 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Evaluating non-randomised intervention studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Prescribers and pharmaceutical representatives: why are we still meeting?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Determinants of the range of drugs prescribed in general practice: a cross-sectional analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

General practitioners and pharmaceutical sales representatives: quality improvement research

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Adding or switching antipsychotic medications in treatment-refractory schizophrenia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

The antibiotic prescribing behaviourof physicians for acute tonsillopharyngitis in primary care

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Physicians and drug representatives: exploring the dynamics of the relationship

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Interactions of doctors with the pharmaceutical industry

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

How conducting a clinical trial affects physicians' guideline adherence and drug preferences.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

The effects and role of direct-to-physician marketing in the pharmaceutical industry: an integrative review.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

The company we keep: why physicians should refuse to see pharmaceutical representatives

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Doctors and drug companies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

New drug uptake: qualitative comparison of high and low prescribing GPs’ attitudes and approach

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Understanding why GPs see pharmaceutical representatives: a qualitative interview study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Influence of commercial information on prescription quantity in primary care

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Sleeping with the enemy? A randomized controlled trial of a collaborative health authority/industry intervention to influence prescribing practice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Physicians and the pharmaceutical industry: is a gift ever just a gift?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Impact of pharmaceutical sales representatives on physician antibiotic prescribing

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

The effect of advertising in clinical software on general practitioners' prescribing behaviour.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Content analysis of drug-detailing by pharmaceutical representatives

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Drug advertising and prescribing

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

The accuracy of drug information from pharmaceutical sales representatives

2 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000352

The drug industry and medical practice--the case of menopausal hormone therapy in Estonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000352

When pharmaceutical manufacturers' employees present grand rounds, what do residents remember?

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000352

Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000352

Impact of visits from pharmaceutical company representatives on antipsychotic prescription in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000352

The association of pharmaceutical company promotional spending with resident physician prescribing behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000352

The effect of industry-independent drug information on the prescribing of benzodiazepines in general practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000352

Marketing and drug costs: who is laughing and crying?

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000352

Effects of Direct-to-Consumer Advertising on Medication Choice: The Case of Antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000352

Physicians, pharmaceutical sales representatives, and the cost of prescribing.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2957394

Changes in drug prescribing patterns related to commercial company funding of continuing medical education

27 November 2018

1 reference

12 December 2020

A survey of the advertising of nine new drugs in the general practice literature

1 reference

12 December 2020

Pharmaceutical promotion and GP prescription behaviour

1 reference

12 December 2020

Differences in prescribing between GPs: impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representatives

1 reference

12 December 2020

Determinants for the adoption of angiotensin II receptor blockers by general practitioners

1 reference

12 December 2020

Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest

1 reference

12 December 2020

Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff

1 reference

12 December 2020

The role of commercial sources in the adoption of a new drug

1 reference

12 December 2020

A Randomized Cohort Study of Diagnostic and Therapeutic Thresholds in Medical Student Clinical Reasoning.

1 reference

12 December 2020

Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene.

1 reference

12 December 2020

Differential education concerning therapeutics and resultant physician prescribing patterns

1 reference

12 December 2020

Rational prescribing and sources of information

1 reference

12 December 2020

Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary

1 reference

12 December 2020

10.1371/JOURNAL.PMED.1000352

Identifiers

DOI

1 reference

1619051

1619051

1 reference

1 reference

1 reference